The Joint Corp. (NASDAQ:JYNT - Get Free Report)'s share price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $10.62 and traded as low as $10.02. Joint shares last traded at $10.10, with a volume of 36,433 shares.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on JYNT shares. Lake Street Capital lowered their price objective on shares of Joint from $20.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday, May 9th. Wall Street Zen lowered shares of Joint from a "buy" rating to a "hold" rating in a research note on Monday, March 17th.
Get Our Latest Report on Joint
Joint Trading Up 0.9%
The firm has a market cap of $160.99 million, a price-to-earnings ratio of -9.23 and a beta of 1.54. The stock's 50 day moving average is $10.48 and its 200 day moving average is $10.92.
Joint (NASDAQ:JYNT - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The firm had revenue of $13.08 million for the quarter, compared to analyst estimates of $13.02 million. Joint had a positive return on equity of 8.24% and a negative net margin of 13.95%. On average, equities research analysts predict that The Joint Corp. will post 0.11 EPS for the current year.
Institutional Trading of Joint
A number of hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets boosted its position in Joint by 6.8% in the fourth quarter. BNP Paribas Financial Markets now owns 24,031 shares of the company's stock valued at $255,000 after buying an additional 1,521 shares in the last quarter. Geode Capital Management LLC boosted its position in Joint by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 293,133 shares of the company's stock valued at $3,116,000 after buying an additional 1,552 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Joint by 51.7% during the fourth quarter. Wells Fargo & Company MN now owns 5,088 shares of the company's stock valued at $54,000 after acquiring an additional 1,735 shares during the last quarter. Barclays PLC raised its stake in shares of Joint by 6.9% during the fourth quarter. Barclays PLC now owns 27,380 shares of the company's stock valued at $291,000 after acquiring an additional 1,771 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Joint by 9.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 36,204 shares of the company's stock valued at $385,000 after acquiring an additional 3,029 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company's stock.
Joint Company Profile
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
See Also
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
